AMRX - Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
IEX Last Trade
8.65
-0.020 -0.231%
Share volume: 964,238
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$8.67
-0.02
-0.23%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-07 | 2023-03-03 | 2023-05-09 | 2023-08-08 | 2023-11-09 | 2024-03-14 | 2024-05-08 | |
| Total revenue | 559.355 M | 545.557 M | 609.759 M | 557.540 M | 599.046 M | 620.040 M | 616.981 M | 659.191 M | |
| Cost of revenue | 353.724 M | 350.653 M | 389.046 M | 379.354 M | 379.025 M | 387.509 M | 427.154 M | 421.131 M | |
| Gross profit | 205.631 M | 194.904 M | 220.713 M | 178.186 M | 220.021 M | 232.531 M | 189.827 M | 238.060 M | |
| -5.22% | 13.24% | -19.27% | 23.48% | 5.69% | -18.36% | 25.41% | |||
| Operating expenses | 149.554 M | 150.306 M | 144.065 M | 140.786 M | 143.369 M | 154.381 M | 155.089 M | 151.893 M | |
| Selling general and admin | 98.806 M | 100.071 M | 102.158 M | 102.096 M | 105.570 M | 113.006 M | 109.003 M | 112.595 M | |
| Research and development | 50.748 M | 50.235 M | 41.907 M | 38.690 M | 37.799 M | 41.375 M | 46.086 M | 39.298 M | |
| Total expenses | 504.099 M | 502.370 M | 534.473 M | 521.784 M | 523.214 M | 542.776 M | 582.721 M | 574.008 M | |
| -0.34% | 6.39% | -2.37% | 0.27% | 3.74% | 7.36% | -1.50% | |||
| Operating income | 55.256 M | 43.187 M | 75.286 M | 35.756 M | 75.832 M | 77.264 M | 34.260 M | 85.183 M | |
| Ebit | 55.256 M | 43.187 M | 75.286 M | 35.756 M | 75.832 M | 77.264 M | 34.260 M | 85.183 M | |
| Pretax income | -232.731 M | 2.180 M | -7.655 M | -9.426 M | 29.660 M | 22.957 M | -83.461 M | -75.522 M | |
| -100.94% | -451.15% | 23.14% | -414.66% | -22.60% | -463.55% | -9.51% | |||
| Income tax | 7.350 M | 4.570 M | -1.797 M | 668.000 K | -23.000 K | -2.076 M | 9.883 M | 6.156 M | |
| Net income basic | -120.808 M | -2.689 M | -4.333 M | -6.943 M | 11.917 M | 9.682 M | -98.649 M | -91.643 M | |
| 97.77% | -61.14% | -60.24% | 271.64% | -18.75% | -1,118.89% | 7.10% | |||
| Net income | -120.808 M | -2.689 M | -4.333 M | -6.943 M | 11.917 M | 9.682 M | -98.649 M | -91.643 M | |
| 97.77% | -61.14% | -60.24% | 271.64% | -18.75% | -1,118.89% | 7.10% |